New research published today in Genome Medicine provides further evidence that international travelers can pick up dangerous drug-resistant bacteria during their journeys and bring it home with them.
The study by US and Dutch scientists analyzed DNA from fecal samples of 190 Dutch travelers before and after they traveled to destinations in South Asia, Southeastern Asia, Northern Africa, and Eastern Africa and found that they brought back 56 unique antimicrobial resistance (AMR) genes, including several of high clinical concern. They also found that the genes acquired-and the changes that occurred in the gut microbiomes of the travellers-were destination specific. On top of that, the researchers identified the acquisition of previously unknown AMR genes that could pose a health threat.
“These broad acquisitions highlight the putative risks that international travel poses to public health by gut resistome perturbation and the global spread of locally endemic AMR genes,” the study authors wrote.
Travel as a risk factor
The detection of AMR genes in people who travel-particularly those traveling to low- and middle-income nations where antibiotic use is high, sanitation is frequently inadequate, and resistant pathogens are more prevalent-in itself is not a novel finding.
Several studies in recent years have identified resistant pathogens and AMR genes in people who’ve traveled to different parts of Asia and Africa. A study published in March in The Lancet Microbe, in fact, found that 74% of the stool samples collected from European visitors to Laos over a 3-week period contained multidrug-resistant bacteria.
“The concept that international travel, or travel of any kind, is a risk factor for microbiome change is fairly well accepted now,” said Gautam Dantas, Phd, co-author of the new study and a professor of pathology and immunology at Washington University in St. Louis (WUSTL) School of Medicine.
But Dantas, along with colleagues at WUSTL School of Medicine and Maastricht University in the Netherlands, hypothesized that those microbiome changes might be destination-specific. To test that hypothesis, they analyzed fecal swab samples from a subset of participants in the Carriage of Multiresistant Bacteria After Travel (COMBAT) study, which includes more than 2,000 participants. The samples were collected before the travelers left on their journey and immediately after they returned.
Instead of culturing the samples to identify the particular bacterial species acquired through travel to the four regions, the researchers conducted shotgun metagenomic sequencing, a process that involves taking the DNA out of all the bacteria in the samples, breaking it up into small pieces, then analyzing all of it for the presence of resistance genes. They matched what they found to a database of known AMR genes.
Overall, the analysis found that travel significantly increased the abundance and diversity of AMR genes in microbiomes of the travelers, with a total of 121 AMR genes acquired by the 190 travelers. The 56 unique AMR genes they detected after travel included tetracycline-resistance genes, fluoroquinolone-resistance genes, extended-spectrum beta-lactamase genes, and MCR-1, the gene that confers resistance to the last-resort antibiotic colistin.
“These are basically middle-aged travelers going on vacation; they’re not going for elective surgery, they’re not going for medical tourism,” said Dantas. “The fact that we found a plasmid-borne copy of a colistin resistance gene, acquired through travel, that’s a concern.”
The results also confirmed the researchers’ hypothesis that the destination may shape the gut microbiome changes. While people traveling to all four regions acquired AMR genes, the abundance and diversity of resistance genes was greatest among those who traveled to Southeastern Asia, and lowest among those who traveled to Northern Africa. Furthermore, the individual resistomes-the collection of resistance genes acquired-looked similar among the people who traveled to the same area.
“Not only do we find these acquisition events across the board, but if you look at those genes that were acquired, the individuals who traveled to the same region tended to have many more genes in common,” Dantas said. “That I think is novel.”
Another novel finding is the identification of previously unknown AMR genes. While many studies of this type focus on well-known resistance elements, Dantas and his colleagues went a step further, using a method known as functional metagenomics. This technique involves taking DNA from the swab samples and inserting it into Eschericia coli bacteria. The researchers then expose the E coli to different antibiotics and sequence the DNA in the surviving bacteria to identify the new genes.